Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience

ConclusionTo our knowledge, this represents the largest single‐center cohort of patients with rheumatic diseases who were exposed to modern cancer immunotherapy. Only a minority of these patients experienced a flare of their preexisting rheumatic disease or any other IRAE.

Source: Arthritis and Rheumatism - February 6, 2018 Category: Rheumatology Authors: Michael D. Richter, Olga Pinkston, Lisa A. Kottschade, Heidi D. Finnes, Svetomir N. Markovic, Uma Thanarajasingam Tags: Brief Report Source Type: research